Table 3.
Characteristic | B | SE | Wald statistic | df | Sig. | HR | 95% CI |
---|---|---|---|---|---|---|---|
Clinical TNM stage | 0.472445 | 0.175108 | 7.279332 | 1 | 0.006975 | 1.603911 | 1.137963–2.260643 |
T | 0.547240 | 0.179851 | 9.258232 | 1 | 0.002344 | 1.728476 | 1.214992–2.458970 |
N | −0.254714 | 0.149093 | 2.918706 | 1 | 0.087558 | 0.775138 | 0.578723–1.038215 |
M | −0.273135 | 0.099921 | 7.472106 | 1 | 0.006266 | 0.760990 | 0.625643–0.925618 |
Tumor diameter (cm) | 0.117830 | 0.152824 | 0.594470 | 1 | 0.440696 | 1.125053 | 0.833852–1.517947 |
Residual tumor | −0.181177 | 0.102099 | 3.148928 | 1 | 0.075977 | 0.834288 | 0.682982–1.019114 |
Neoadjuvant treatment | −0.024768 | 0.583556 | 0.001801 | 1 | 0.966145 | 0.975536 | 0.310827–3.061734 |
Radiation therapy | −0.133596 | 0.252688 | 0.279522 | 1 | 0.597014 | 0.874944 | 0.533202–1.435716 |
Targeted molecular therapy | 0.430070 | 0.209421 | 4.217337 | 1 | 0.040013 | 1.537365 | 1.019806–2.317588 |